AQST

SEC source: 0001214659-25-004226 · marketforms-68575.xml · nonDerivative · entry 2

TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,102

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004226 · marketforms-68575.xml · nonDerivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 358,295

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004228 · marketforms-68577.xml · derivative · entry 5

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 2

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,555

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 1

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,414

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004227 · marketforms-68571.xml · derivative · entry 6

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,705

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 2

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,066

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004225 · marketforms-68573.xml · derivative · entry 3

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004225 · marketforms-68573.xml · nonDerivative · entry 2

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,566

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004225 · marketforms-68573.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,681

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment

SEC source: 0001214659-25-004223 · marketforms-68569.xml · derivative · entry 4

BRAENDER LORI J · CIK 0001752955 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004223 · marketforms-68569.xml · nonDerivative · entry 2

BRAENDER LORI J · CIK 0001752955 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,639

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004223 · marketforms-68569.xml · nonDerivative · entry 1

BRAENDER LORI J · CIK 0001752955 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 423,231

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004222 · marketforms-68504.xml · derivative · entry 4

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004222 · marketforms-68504.xml · nonDerivative · entry 2

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,004

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004222 · marketforms-68504.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,628

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004221 · marketforms-68502.xml · derivative · entry 4

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 408,000

Underlying: Common Stock · 408,000 shares

Expires 2025-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-25-004221 · marketforms-68502.xml · nonDerivative · entry 2

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,069,171

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-25-004221 · marketforms-68502.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,098,478

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-26-004593 · marketforms-72933.xml · derivative · entry 1

Korczynski Sherry · CIK 0002026090 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Common Stock · 67,500 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0001214659-26-004594 · marketforms-72932.xml · derivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,500

Underlying: Common Stock · 82,500 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0001214659-26-004596 · marketforms-72925.xml · derivative · entry 1

Boyd Peter E. · CIK 0001739816 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0001214659-26-004597 · marketforms-72912.xml · derivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,100

Underlying: Common Stock · 293,100 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0001214659-26-004595 · marketforms-72927.xml · derivative · entry 1

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0001214659-26-004592 · marketforms-72926.xml · derivative · entry 1

BRAENDER LORI J · CIK 0001752955 · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,500

Underlying: Common Stock · 82,500 shares

Expires 2028-03-07

F1 · security: This Form 4 was filed late due to an inadvertent administrative oversight.

F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

F2 · derivative.exercise_date: Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

SEC source: 0000950170-24-133320 · ownership.xml · nonDerivative · entry 1

BRATTON DOUGLAS K · CIK 0001281933 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 199,841

F1 · balance_after: These shares of common stock of Aquestive Therapeutics, Inc. (the "Issuer") are held by family trusts and entities controlled by Douglas K. Bratton. Such shares of common stock were acquired in previously reported in-kind pro rata distributions for no consideration without a change in pecuniary interest.

F1 · ownership.nature: These shares of common stock of Aquestive Therapeutics, Inc. (the "Issuer") are held by family trusts and entities controlled by Douglas K. Bratton. Such shares of common stock were acquired in previously reported in-kind pro rata distributions for no consideration without a change in pecuniary interest.

SEC source: 0001214659-24-019685 · marketforms-67449.xml · nonDerivative · entry 2

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · by spouse IRA

Disclosed balance after: 0

F1 · shares: Shares owned by spouse who shares Ms. Jung's household. Ms. Jung disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16(a) of the Securities Exchange Act of 1940, as amended, or for any other purpose.

SEC source: 0001214659-24-014226 · marketforms-66654.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,681

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-011216 · marketforms-66325.xml · derivative · entry 2

COSTA SANTO J · CIK 0001013419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Costa's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011218 · marketforms-66326.xml · derivative · entry 1

Krop Julie · CIK 0001643127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011220 · marketforms-66327.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011217 · marketforms-66324.xml · derivative · entry 2

Cochran John · CIK 0001406773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011221 · marketforms-66328.xml · derivative · entry 1

MORRIS TIMOTHY E · CIK 0001191286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 25, 2025, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-011219 · marketforms-66323.xml · derivative · entry 2

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2034-06-20

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001214659-24-010798 · marketforms-66306.xml · nonDerivative · entry 1

Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-24-008874 · marketforms-65653.xml · nonDerivative · entry 1

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,963

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

SEC source: 0001214659-24-008873 · marketforms-65565.xml · derivative · entry 1

Jenkins Abigail L. · CIK 0001947032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,000

Underlying: Common Stock · 57,000 shares

Expires 2034-05-10

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 10, 2025.

SEC source: 0001214659-24-004795 · marketforms-65280.xml · nonDerivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 984,476

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 6, 2023.

SEC source: 0001214659-24-004391 · marketforms-65149.xml · nonDerivative · entry 2

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,963

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004390 · marketforms-65150.xml · nonDerivative · entry 4

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,754

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004389 · marketforms-65141.xml · nonDerivative · entry 2

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,034,476

F3 · kind: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004392 · marketforms-65148.xml · nonDerivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,295

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004395 · marketforms-65145.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 845,364

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004394 · marketforms-65146.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,628

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004393 · marketforms-65147.xml · nonDerivative · entry 1

BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,231

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004391 · marketforms-65149.xml · nonDerivative · entry 1

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,650

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-004390 · marketforms-65150.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,886

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC source: 0001214659-24-017011 · marketforms-67099.xml · nonDerivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 980,726

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .

SEC source: 0001214659-24-017010 · marketforms-67100.xml · nonDerivative · entry 1

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,414

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .